Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: A prospective study

European Journal of Neurology

Volumn 16, Issue 7, 2009, Pages 808-813

  Kivipelto, M ^a,b,c   Annerbo, S ^d   Hultdin, J ^e   Backman L ^b   Viitanen, M ^c,d   Fratiglioni, L ^b   Lokk J ^c  

^a AGING RESEARCH CENTER   (Sweden)

^b STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimers disease; Dementia; Holo transcobalamin; Homocysteine

Indexed keywords

HOMOCYSTEINE; TRANSCOBALAMIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COMMUNITY HEALTH PLANNING; DEMENTIA; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MODELS, ANATOMIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRANSCOBALAMINS;

EID: 66749189122     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02590.x     Document Type: Article

References (40)

1. Smith AD. The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food and Nutrition Bulletin 2008 29 : S143 S172.
2. Kivipelto M, Helkala EL, Hänninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001 56 : 1683 1689. (Pubitemid 32574567)
3. Wang HX, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol 2002 155 : 1081 1087. (Pubitemid 34625496)
4. Schmand B, Smit J, Lindeboom J, et al. Low education is a genuine risk factor for accelerated memory decline and dementia. JCE 1997 50 : 1025 1033. (Pubitemid 27450363)
5. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991 82 : 339 359.
6. 12 and folate tissue deficiency markers amongst elderly Swedes - a population-based study. J Intern Med 2001 249 : 423 432. (Pubitemid 34208946)
7. Clarke R, Grimley Evans J, Schneede J, et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004 33 : 34 41. (Pubitemid 38111446)
8. 12 and folate status on episodic memory performance in very old age: a population based study. Psychol Aging 1996 11 : 487 496. (Pubitemid 26355251)
9. 12 and folat in relation to the development of Alzheimer′s disease. Neurology 2001 56 : 1188 1194. (Pubitemid 32405713)
10. Basun H, Fratiglioni L, Winblad B. Cobalamin levels are not reduced in Alzheimer′s disease: results from a population-based study. J Am Geriatr Soc 1994 42 : 132 136. (Pubitemid 24057347)
11. 12 deficiency? J Intern Med 2005 257 : 289 298. (Pubitemid 40342132)
12. Zetterberg M, Nexø E, Regland B, et al. The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease. Clin Chem 2003 49 : 1195 1198. (Pubitemid 36751113)
13. Quadri P, Fragiacomo C, Pezzati R, et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004 80 : 114 122. (Pubitemid 41115564)
14. Li Z, Sun L, Zhang H, et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylentetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke. A Multicenter Case-Control Study in China. Stroke 2003 34 : 2085 2090. (Pubitemid 37099816)
15. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000 355 : 523 527. (Pubitemid 30088671)
16. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylentetrahydrofolate reductase genotype, and risk for stroke, vascular dementia and Alzheimer′s disease in Northern Ireland. Stroke 2002 33 : 2351 2356.
17. McCaddon A, Davis G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998 13 : 235 239. (Pubitemid 28194997)
18. 12, and serum total homocysteine levels in confirmed Alzheimer′s disease. Arch Neurol 1998 55 : 1449 1455. (Pubitemid 28525506)
19. Mizrahi EH, Bowirrat A, Jacobsen DW, et al. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs. J Neurol Sci 2004 227 : 109 113. (Pubitemid 39491133)
20. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004 62 : 1972 1976. (Pubitemid 38738206)
21. Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 2002 58 : 1471 1475. (Pubitemid 34552951)
22. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002 346 : 476 483. (Pubitemid 34441738)
23. Haan MN, Miller JW, Aiello AE, et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment; results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2007 85 : 511 517. (Pubitemid 46220956)
24. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer's disease. Am J Clin Nutr 2005 82 : 636 643. (Pubitemid 43759250)
25. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007 64 : 86 92. (Pubitemid 46072428)
26. Refsum H, Smith AD. Low vitamin B-12 status in confirmed Alzheimer′s disease as revealed by serum holo-Transcobalamin. J Neurol Neurosurg Psychiatry 2003 74 : 959 961. (Pubitemid 36783006)
27. Fratiglioni L, Viitanen M, Bäckman L, Sandman PO, Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 1992b 11 (Suppl. 1 29 36.
28. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised (DSM-III-R). Washington, DC : American Psychiatric Association, 1987 pp. 97 163.
29. Kim J-M, Stewart R, Kim S-W, et al. Changes in folate, vitamin B12 and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiatry 2008 79 : 864 868.
30. Porter RH, Roberts PJ. Glutamate metabotropic receptor activation in neonatal rat cerebral cortex by sulphur-containing excitatory amino acids. Neurosci Lett 1993 154 : 78 80. (Pubitemid 23172325)
31. Smirnova T, Stinnakre J, Mallet J. Characterization of presynaptic glutamate receptor. Science 1993 262 : 430 433.
32. Schatz RA, Wilens TE, Sellinger OZ. Decreased in vivo protein and phospholipids methylation after in vivo elevation of brain S-adenosyl-1- homocysteine. Biochem Biophys Res Commun 1981 98 : 1097 10107.
33. Schatz RA, Wilens TE, Sellinger OZ. Decreased transmethylation of biogenetic amines after in vivo elevation of brain S-adenosyl-1-homocysteine. J Neurochem 1981a 36 : 1739 1748. (Pubitemid 11083547)
34. Schneede J, Refsum H, Ueland PM. Biological and Environmental Determinants of Plasma Homocysteine. Semin Thromb Hemost 2000 26 : 263 279.
35. 12: effects of replacement therapy on dementia. J Neurol 1996 243 : 522 529. (Pubitemid 26239706)
36. Hvas A-M, Juul S, Lauritzen L, Nexø E, Ellegard J. No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. J Affect Disord 2004 81 : 269 273. (Pubitemid 39141916)
37. Bønaa KH, Njølstad A, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006 354 : 1578 1588.
38. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. J Am Med Assoc 2004 291 : 565 575. (Pubitemid 38500310)
39. Durga J, van Boxtel MPJ, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomized, double blind, controlled trial. Lancet 2007 369 : 208 216. (Pubitemid 46107683)
40. Nilsson K, Gustafson L, Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001 16 : 609 614. (Pubitemid 32618854)